CARACTERÍSTICAS DA MORBIMORTALIDADE POR COVID-19 EM CRIANÇAS E ADOLESCENTES: REVISÃO DE ESCOPO
DOI:
https://doi.org/10.31011/reaid-2024-v.98-n.3-art.2037Palavras-chave:
COVID-19, Criança, Adolescente, RevisãoResumo
Introdução: A pandemia de Covid-19 representou um desafio para os sistemas de saúde em todo o mundo e para o entendimento dos fatores que contribuíram para as diferenças nos perfis de morbimortalidade entre os grupos populacionais, especialmente, entre crianças e adolescentes. Objetivo: mapear na literatura científica os fatores que interferiram na morbimortalidade por Covid-19 em crianças e adolescentes Método: Trata-se de uma revisão de escopo (scoping review) com base no modelo proposto pelo Joanna Briggs Institute (JBI) a partir da questão norteadora da pesquisa, que foi definida como: Quais fatores interferiram na morbidade e mortalidade de Covid-19 em crianças e adolescentes? Resultado: Foram selecionados para a revisão 21 artigos. Entre os estudos selecionados, 6 mostraram que crianças e adolescentes de 0 a 18 anos com uma ou mais comorbidades, foram os pacientes infantojuvenis mais presentes em Unidades de Terapia Intensiva e apresentaram maior chance de óbito pela Covid-19. Destaca-se que em 3 estudos analisados, crianças abaixo de 1 ano representaram maior risco de óbito pela doença. Conclusão: Este estudo destacou os fatores que interferem na morbimortalidade por Covid-19 na população infantojuvenil, como a presença de comorbidades, menores de um ano, sexo masculino e a raça negra; além da situação vacinal.
Downloads
Referências
Michelon CM. Main SARS-CoV-2 variants notified in Brazil. Revista Brasileira de Análises Clínicas. 2021;53(2). DOI: 10.21877/2448-3877.202100961
Massuda A, Malik AM, Vecina Neto G, Tasca R, FERREIRA JUNIOR WC. A resiliência do Sistema Único de Saúde frente à COVID-19. Cadernos EBAPEBR. 2021. [cited 2023 Oct 4];19(spe):735–44. DOI: https://doi.org/10.1590/1679-395120200185
Ministério da Saúde (BR), Secretaria de Vigilância em Saúde e Ambiente. Boletim epidemiológico especial: Doença pelo Coronavírus – Covid-19, no152 [Internet]. 2023 [cited 2023 Oct 5]. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/covid-19/2023/boletim-epidemiologico-no-152-boletim-coe-coronavirus/view
Oliveira WA, Silva JL, Andrade ALM, Micheli D, Carlos DM, Silva MAI. A saúde do adolescente em tempos da COVID-19: scoping review. Cad Saude Publica. 2020. [cited 2023 Oct 5];36(8):e00150020. DOI: https://doi.org/10.1590/0102-311X00150020
Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Imunização e Doenças Transmissíveis. Plano Nacional de Operacionalização da Vacinação contra a Covid-19 [Internet]. 2022 [cited 2023 Oct 5]. Available from: http://bvsms.saude.gov.br/ bvs/publicações /plano_nacional_operacionalizacao_vacinacao _covid19.pdf
Nikolopoulou GB, Maltezou HC. COVID-19 in Children: Where do we Stand? Arch Med Res. 2022. [cited 2023 Oct 5];53(1):1–8. DOI: 10.1016/j.arcmed.2021.07.002
Miller AD, Zambrano LD, Yousaf AR, Abrams JY, Meng L, Wu MJ, et al. Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021. Clin Infect Dis. 2022. [cited 2023 Oct 5];75(1):E1165–75. DOI: 10.1093/cid/ciab1007
Hasan MR, Al Zubaidi K, Diab K, Hejazi Y, Bout-Tabaku S, Al-Adba B, et al. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a case series from a tertiary care pediatric hospital in Qatar. BMC Pediatr. 2021.[cited 2023 Oct 5];21(1). DOI: 10.1186/s12887-021-02743-8
Acevedo L, Piñeres-Olave BE, Niño-Serna LF, Vega LM, Gomez IJA, Chacón S, et al. Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study). BMC Pediatr. 2021. [cited 2023 Oct 5];21(1). DOI: 10.1186/s12887-021-02974-9
Tiwari A, Balan S, Rauf A, Kappanayil M, Kesavan S, Raj M, et al. COVID-19 related multisystem inflammatory syndrome in children (MIS-C): a hospital-based prospective cohort study from Kerala, India. BMJ Paediatr Open. 2021. [cited 2023 Oct 5];5(1). DOI: 10.1136/bmjpo-2021-001195
Santos AAL, Silva JP, Silva TCL, Souza TA, Miranda FAN, Torres GV. Influência de indicadores sociais na incidência e mortalidade da COVID-19 no Brasil em Junho de 2020. Saúde e Pesquisa. 2022. [cited 2023 Oct 5];15(1):1–10. DOI: https://doi.org/10.17765/2176-9206.2022v15n1.e9559
Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADDN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021.[cited 2023 Oct 10];74:e20200624. DOI: https://doi.org/10.1590/0034-7167-2020-0624
Balakrishnan V, NG WZ, Soo MC, Han GJ, Lee CJ. Infodemic and fake news – A comprehensive overview of its global magnitude during the COVID-19 pandemic in 2021: A scoping review. International Journal of Disaster Risk Reduction. 2022. [cited 2023 Oct 5];78:103144. DOI: 10.1016/j.ijdrr.2022.103144
Zhao S, Hu S, Zhou X, Song S, Wang Q, Zheng H, et al. The Prevalence, Features, Influencing Factors, and Solutions for COVID-19 Vaccine Misinformation: Systematic Review. JMIR Public Health Surveill. 2023 [cited 2023 Oct 5];9. DOI: 10.2196/40201
Wen J, Du X, Li A, Zhang S, Shen S, Zhang Z, et al. Dilemmas and options for COVID-19 vaccination in children. Ital J Pediatr [Internet]. 2023 Dec 1 [cited 2023 Oct 5];49(1):1–10. DOI: https://doi.org/10.1186/s13052-023-01513-9
Galhardi CP, Freire NP, Fagundes MCM, Minayo MC de S, Cunha ICKO. Fake news e hesitação vacinal no contexto da pandemia da COVID-19 no Brasil. Cien Saude Colet [Internet]. 2022 May 4 [cited 2023 Oct 5];27(5):1849–58. DOI: https://doi.org/10.1590/1413-81232022275 .24092021
Aromataris E, Munn Z (Editors). JBI Manual for Evidence Synthesis [Internet]. JBI Manual for Evidence Synthesis. JBI; 2020 [cited 2023 Oct 4]. Available from: https://jbi-global-wiki.refined.site/space/MANUAL
Fabbri S, Silva C, Hernandes E, Octaviano F, Di Thommazo A, Belgamo A. Improvements in the StArt tool to better support the systematic review process. Proceedings of the 20th International Conference on Evaluation and Assessment in Software Engineering. 2016 Jun 1;01-03-June-2016. DOI: 10.1145/2915970.2916013
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018 Oct 2;169(7):467–73. DOI: https://doi.org/10.7326/M18-0850
Nachega JB, Sam-Agudu NA, MacHekano RN, Rabie H, Van Der Zalm MM, Redfern A, et al. Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries. JAMA Pediatr. 2022. [cited 2023 Oct 5];176(3):E216436. DOI: 10.1001/jamapediatria.2021.6436
Bai K, Liu W, Liu C, Fu Y, Hu J, Qin Y, et al. Clinical Analysis of 25 COVID-19 Infections in Children. Pediatric Infectious Disease Journal. 2020 Jul 1 [cited 2023 Oct 4];39(7):E100–3. DOI: 10.1097/INF.0000000000002740
Rao S, Gavali V, Prabhu SS, Mathur R, Dabre LR, Prabhu SB, et al. Outcome of Children Admitted With SARS-CoV-2 Infection: Experiences From a Pediatric Public Hospital. Indian Pediatr. 2021;358. DOI: 10.1007/s13312-021-2196-4
Madani S, Shahin S, Yoosefi M, Ahmadi N, Ghasemi E, Koolaji S, et al. Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran. BMC Pediatr. 2021.[cited 2023 Oct 9];21(1). DOI: 10.1186/s12887-021-03030-2
Chaiyakulsil C, Sritipsukho P, Satdhabudha A, Bunjoungmanee P, Tangsathapornpong A, Sinlapamongkolkul P, et al. An epidemiological study of pediatric COVID-19 in the era of the variant of concern. PLoS One. 2022. [cited 2023 Oct 5];17(4). DOI: 10.1371/journal.pone.0267035
Mamishi S, Pourakbari B, Mehdizadeh M, Navaeian A, Eshaghi H, Yaghmaei B, et al. Children with SARS-CoV-2 infection during the novel coronaviral disease (COVID-19) outbreak in Iran: an alarming concern for severity and mortality of the disease. BMC Infect Dis. 2022. [cited 2023 Oct 5];22(1):382. DOI: https://doi.org/10.1186/s12879-022-07200-0
Alnajjar AA, Dohain AM, Abdelmohsen GA, Alahmadi TS, Zaher ZF, Abdelgalil AA. Clinical characteristics and outcomes of children with COVID-19 in Saudi Arabia. Saudi Med J. 2021. [cited 2023 Oct 4];42(4):391–8. DOI: 10.15537/smj.2021.42.4.20210011
Singh P, Attri K, Mahto D, Kumar V, Kapoor D, Seth A, et al. Clinical Profile of COVID-19 Illness in Children-Experience from a Tertiary Care Hospital. Indian J Pediatr. 2022. [cited 2023 Oct 5];89(1):45–51. DOI: 10.1007/s12098-021-03822-5
Kufa T, Jassat W, Cohen C, Tempia S, Masha M, Wolter N, et al. Epidemiology of SARS-CoV-2 infection and SARS-CoV-2 positive hospital admissions among children in South Africa. Influenza Other Respir Viruses. 2022. [cited 2023 Oct 9];16(1):34–47. DOI: 10.1111/irv.12916
Drouin O, Hepburn CM, Farrar DS, Baerg K, Chan K, Cyr C, et al. Characteristics of children admitted to hospital with acute SARS-CoV-2 infection in Canada in 2020. CMAJ. 2021.[cited 2023 Oct 9];193(38):E1483–93. DOI: 10.1503/cmaj.210053
MacIas-Parra M, Fortes-Gutierrez S, Aguilar-Gomez N, Diaz-Garcia L, Otero-Mendoza F, Arias De La Garza E, et al. Clinical and Epidemiological Characteristics of Paediatric Patients Diagnosed with COVID-19 in a Tertiary Hospital in Mexico City. J Trop Pediatr. 2021.[cited 2023 Oct 9];67(3). DOI: 10.1093/tropej/fmab025
Kim TY, Kim EC, Agudelo AZ, Friedman L. COVID-19 hospitalization rate in children across a private hospital network in the United States: COVID-19 hospitalization rate in children. Arch Pediatr. 2021.[cited 2023 Oct 9];28(7):530–2. DOI: 10.1016/j.arcped.2021.07.004
Gumus H, Ozcan Y, Kazanasmaz H, Demir A, Guzelcicek A. Clinical Characteristics of COVID-19 Infection in the Pediatric Age Group. Electronic Journal of General Medicine. 2021. [cited 2023 Oct 5];18(5):em308. DOI: https://doi.org/10.29333/ejgm/11019
Kari JA, Shalaby MA, Albanna AS, Alahmadi TS, Sukkar SA, MohamedNur HAH, et al. Coronavirus disease in children: A multicentre study from the Kingdom of Saudi Arabia. J Infect Public Health. 2021.[cited 2023 Oct 9];14(4):543. doi: 10.1016/j.jiph.2021.01.011
Desai A, Mills AM, Delozier S, Cabrera Aviles C, Edwards A, Dirajlal-Fargo S, et al. Pediatric Patients with SARS-CoV-2 Infection: Clinical Characteristics in the United States from a Large Global Health Research Network. Cureus. 2020.[cited 2023 Oct 9];12(9). DOI: 10.7759/cureus.10413
Baki AA, Zaky S, Hosny H, Elassal G, Abdelbary A, Said A, et al. Covid-19 in egyptian children: A multicenter study. J Pediatr Infect Dis. 2021.[cited 2023 Oct 5];16(2):57–61. DOI: 10.1055/s-0040-1722284
Armin S, Mirkarimi M, Pourmoghaddas Z, Tariverdi M, Jafrasteh A, Marhamati N, et al. Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics. Can J Infect Dis Med Microbiol. 2021. [cited 2023 Oct 9];2021. DOI: 10.1155/2021/4914371
Morais LL, Fernandes TG, Mendonça ASGB. Clinical characteristics of hospitalized pediatric patients with COVID-19 in a reference hospital in Manaus, Amazonas, Brazil. Revista de Epidemiologia e Controle de Infecção. 2021. [cited 2023 Oct 10];11(1):06–11. DOI: https://doi.org/10.17058/reci.v1i1.15534
Lopes ASA, Fontes Vieira SC, Lima Santos Porto R, Santana Santos V, Fontes Leite DC, Eduardo Cuevas L, et al. Coronavirus disease‐19 deaths among children and adolescents in an area of Northeast, Brazil: why so many? Tropical Medicine & International Health. 2020.[cited 2023 Oct 5];26(1):115–9. DOI: https://doi.org/10.1111/tmi.13529
Sena GR, Lima TPF, Vidal SA, Do Carmo Duarte MMB, Bezerra PGM, Fonseca Lima EJ, et al. Clinical Characteristics and Mortality Profile of COVID-19 Patients Aged less than 20 years Old in Pernambuco - Brazil. Am J Trop Med Hyg. 2021.[cited 2023 Oct 5];104(4):1507–12. DOI: 10.4269/ajtmh.20-1368
Parcha V, Booker KS, Kalra R, Kuranz S, Berra L, Arora G, et al. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Sci Rep. 2021. [cited 2023 Oct 5];11(1). DOI: 10.1038/s41598-021-89553-1
Peckham H, Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020. [cited 2023 Oct 9];11(1). DOI: 10.1038/s41467-020-19741-6
Fergie J, Moran MM, Cane A, Pather S, Türeci Ӧzlem, Srivastava A. COVID-19 Epidemiology, Immunity, and Vaccine Development in Children: A Review. Vaccines (Basel). 2022. [cited 2023 Oct 9];10(12). DOI: 10.3390/vacinas10122039
Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2021.[cited 2023 Oct 10];103:246–56. DOI: 10.1016/j.ijid.2020.11.163
Madani S, Shahin S, Yoosefi M, Ahmadi N, Ghasemi E, Koolaji S, et al. Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran. BMC Pediatr. 2021. [cited 2023 Oct 5];21(1). DOI: 10.1186/s12887-021-03030-2
Nogueira-de-Almeida CA, Del Ciampo LA, Ferraz IS, Del Ciampo IRL, Contini AA, Ued F da V. COVID-19 and obesity in childhood and adolescence: a clinical review. J Pediatr (Rio J). 2020. [cited 2023 Oct 9];96(5):546–58. DOI: 10.1016/j.jped.2020.07.001
Brambilla I, Cave FD, Guarracino C, De Filippo M, Votto M, Licari A, et al. Obesity and COVID-19 in children and adolescents: a double pandemic. Acta Biomed. 2022. [cited 2023 Oct 10];93(S3). DOI: 10.23750/abm.v93iS3.13075
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
